As of 2025-06-24, the Fair Value of Mesoblast Ltd (MSB.AX) is -0.63 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.56 AUD, the upside of Mesoblast Ltd is -140.07%.
With the market price of 1.56 AUD and our fair value calculation, Mesoblast Ltd (MSB.AX) is not a good investment. Investing in MSB.AX stocks now will result in a potential loss of 140.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -77.94 | -98.81 | -91.35 | -81.89 | -87.96 | -87.59 |
| YoY growth | 13.21% | -26.78% | 7.55% | 10.35% | -7.41% | -0.61% |
| Market Cap (mil) | 1,999.73 |
| P/E | |
| Forward P/E |
| EPS | -0.08 |
| Avg earnings growth rate | -0.61% |
| TTM earnings | -103.35 |